SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-010122
Filing Date
2020-03-11
Accepted
2020-03-11 17:01:44
Documents
78
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cnat-10k_20191231.htm 10-K 2610718
2 EX-4.5 cnat-ex45_307.htm EX-4.5 28080
3 EX-10.39 cnat-ex1039_306.htm EX-10.39 66354
4 EX-23.1 cnat-ex231_8.htm EX-23.1 5690
5 EX-31.1 cnat-ex311_6.htm EX-31.1 9490
6 EX-31.2 cnat-ex312_9.htm EX-31.2 10903
7 EX-32.1 cnat-ex321_10.htm EX-32.1 6130
8 EX-32.2 cnat-ex322_7.htm EX-32.2 6593
  Complete submission text file 0001564590-20-010122.txt   8637559

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT cnat-20191231.xml EX-101.INS 1792137
10 XBRL TAXONOMY EXTENSION SCHEMA cnat-20191231.xsd EX-101.SCH 55203
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20191231_cal.xml EX-101.CAL 56133
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20191231_def.xml EX-101.DEF 184743
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20191231_lab.xml EX-101.LAB 481836
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20191231_pre.xml EX-101.PRE 364147
Mailing Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE SUITE 250 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36003 | Film No.: 20706025
SIC: 2834 Pharmaceutical Preparations